Russia and Mexico have just signed an agreement to package the Sputnik V vaccine at the facilities of the state-owned company Laboratorios de Biológicos y Reactivos de México (Birmex). With this agreement, the Latin American country would fill three biologicals in its territory.
In recent days, the director of the firm, Pedro Zenteno Santaella, had traveled to Russia with the intention of signing contracts to receive technology from the Russian Direct Investment Fund (RDIF), to package the vaccine in Birmex laboratories.
It was until this Thursday, October 14, that the signing of the agreement was made official, which establishes the mechanisms and conditions necessary for the process of technological and analytical transfer for the production of the Sputnik V vaccine in the Latin American nation.
“Today the agreement that will make history in Mexico was signed!“Birmex announced on its Twitter account.
At the end of April, the Mexican Foreign Minister, Marcelo Ebrard, made an official visit to Russia that had, among its main reasons, agreeing on the details so that the Latin American nation could perform the filling and packaging of the Sputnik V vaccine.
As part of these approaches, on July 5, Birmex produced the first test batch of Sputnik V in collaboration with the Russian Fund for Direct Investment.
They produce a test batch of Sputnik V in Mexico https://t.co/cNPSI0tiIdThe Russian Fund for Direct Investment and the pharmaceutical company Laboratorios de Biológicos y Reactivos de México announced the production of a test batch of the Russian vaccine against covid-19 Sputnik V pic.twitter.com/Va6Np691D4
– MRT in Spanish (@ActualidadMRT) July 5, 2021
Along with the agreement for the packaging of Sputnik in Latin American territory, the Mexican Government and the RDIF signed a contract for the delivery of 24 million doses of the Russian vaccine, to immunize 12 million citizens.
Until this Thursday, the Russian Fund has Sent 8.9 million doses of Sputnik V to Mexico.
Production in Mexico
On the other hand, Mexico is currently filling two anticovid vaccines in the territory.
The Drugmex laboratory (based in Querétaro) is responsible for packaging the Chinese drug CanSino Biologics, while Liomont (Mexico City) receives the active substance from AstraZeneca that manufactures the Argentine company mAbxience and completes the packaging.
After the agreement signed this Thursday with the RDIF, Mexico will package a third vaccine in its territory in the following months.
If you found it interesting, share it with your friends.
Disclaimer: This article is generated from the feed and not edited by our team.